Study on The Timing of Clopidogrel and The Prognosis of Stent-implanted Patients
碩士 === 國立成功大學 === 臨床藥學研究所 === 95 === Background/ Aims: Clopidogrel 300mg loading dose has been shown to benefit patients who undergo percutaneous coronary intervention (PCI) after short-term or long -term follow up in big clinical trials. Guidelines either in American College of Cardiology/American...
Main Authors: | Yu-ting Chang, 張玉婷 |
---|---|
Other Authors: | Yea-Huei Kao |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/71605020252612306790 |
Similar Items
-
Ausência de interação clopidogrel-estatina em pacientes submetidos a implante de "stent" coronário Ausencia de interacción clopidogrel-estatina en pacientes sometidos a implante de "Stent" coronario Lack of clopidogrel-statin interaction in patients undergoing coronary stent implantation
by: Carlos Vicente Serrano Júnior, et al.
Published: (2010-09-01) -
Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
by: Jong-Won Chung, et al.
Published: (2019-01-01) -
Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation
by: Yalçın Velibey, et al.
Published: (2018-07-01) -
A study of genetic variation in metabolism of clopidogrel in patients with stent thrombosis
by: A. Ghosh Chaudhury, et al.
Published: (2017-11-01) -
Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
by: Rakesh K Sharma, et al.
Published: (2009-11-01)